Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Creatine phosphokinase activity during lithium treatment.

R Gosling, R J Kerry, G Owen

    British Medical Journal
    |August 5, 1972
    PubMed
    Summary

    Lithium carbonate treatment for manic depressive illness can cause creatine phosphokinase (C.P.K.) increases in stable patients. These elevated C.P.K. levels may indicate controlled disease activity during adequate serum lithium levels.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prioritising in a crisis: what next for malaria research?

    Malaria journal·2026
    Same author

    Gastric cancer hospital-based registry: real-world gastric cancer data from Latin America and Europe.

    ESMO gastrointestinal oncology·2026
    Same author

    Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project.

    ESMO open·2025
    Same author

    A sensitive method for the recovery of Escherichia coli serogroup O55 including Shiga toxin-producing variants for potential use in outbreaks.

    Journal of applied microbiology·2019
    Same author

    How do pig farms maintain low Salmonella prevalence: a case-control study.

    Epidemiology and infection·2018
    Same author

    Is there a correlation between malaria incidence and IRS coverage in western Zambezi region, Namibia?

    Public health action·2018

    Area of Science:

    • Biochemistry
    • Psychiatry
    • Pharmacology

    Background:

    • Manic depressive illness (bipolar disorder) is a significant psychiatric condition.
    • Lithium carbonate is a common mood stabilizer for bipolar disorder.
    • Monitoring treatment efficacy and potential side effects is crucial.

    Purpose of the Study:

    • To investigate the occurrence and significance of elevated creatine phosphokinase (C.P.K.) activity in patients with manic depressive illness treated with lithium carbonate.
    • To determine if raised C.P.K. activity correlates with disease stability or activity.

    Main Methods:

    • Observational study of patients with manic depressive illness receiving lithium carbonate.
    • Measurement of serum creatine phosphokinase (C.P.K.) activity.
    • Monitoring of clinical status and serum lithium levels.

    Main Results:

    • Occasional large increases in C.P.K. activity were observed in patients treated with lithium carbonate.
    • Elevated C.P.K. levels occurred when patients were mood-stable and clinically well.
    • Adequate serum lithium levels were confirmed in all cases with raised C.P.K. activity.

    Conclusions:

    • Elevated C.P.K. activity in patients on lithium carbonate may not indicate active disease but rather controlled disease activity.
    • This finding suggests C.P.K. levels could be a biochemical marker of lithium's therapeutic effect in manic depressive illness.

    Related Experiment Videos